Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Humbert

Showing results (271-280 of 327) with videos related to

Pageof 33
Sort By:
The European Respiratory Journal|September 11, 2004
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2M Humbert, R J Barst, I M Robbins, et al.
Annals of the Rheumatic Diseases|March 19, 2009
Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung diseaseB Terrier, M C Tamby, L Camoin, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1996
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entityM Humbert, S R Durham, S Ying, et al.
The European Respiratory Journal|April 16, 2004
Chronic thromboembolic pulmonary hypertensionP Dartevelle, E Fadel, S Mussot, et al.
Clinical Genetics|June 10, 2011
ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertensionM Eyries, F Coulet, B Girerd, et al.
The European Respiratory Journal|August 9, 2002
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesisM Humbert, P Labrune, O Sitbon, et al.
Rheumatology (Oxford, England)|August 22, 2006
Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosisO Distler, F Behrens, D Huscher, et al.
The European Respiratory Journal|June 2, 2009
Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous diseaseH Khaldi, S Marchand-Adam, C Kannengiesser, et al.
The European Respiratory Journal|October 3, 2002
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivativesM Humbert, Z Deng, G Simonneau, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Surgical treatment of chronic thromboembolic pulmonary hypertension]P Dartevelle, E Fadel, S Mussot, et al.
Pageof 33

Showing results (271-280 of 327) with videos related to

Sort By:
Pageof 33
The European Respiratory Journal|September 11, 2004
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2M Humbert, R J Barst, I M Robbins, et al.
Annals of the Rheumatic Diseases|March 19, 2009
Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung diseaseB Terrier, M C Tamby, L Camoin, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1996
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entityM Humbert, S R Durham, S Ying, et al.
The European Respiratory Journal|April 16, 2004
Chronic thromboembolic pulmonary hypertensionP Dartevelle, E Fadel, S Mussot, et al.
Clinical Genetics|June 10, 2011
ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertensionM Eyries, F Coulet, B Girerd, et al.
The European Respiratory Journal|August 9, 2002
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesisM Humbert, P Labrune, O Sitbon, et al.
Rheumatology (Oxford, England)|August 22, 2006
Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosisO Distler, F Behrens, D Huscher, et al.
The European Respiratory Journal|June 2, 2009
Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous diseaseH Khaldi, S Marchand-Adam, C Kannengiesser, et al.
The European Respiratory Journal|October 3, 2002
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivativesM Humbert, Z Deng, G Simonneau, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Surgical treatment of chronic thromboembolic pulmonary hypertension]P Dartevelle, E Fadel, S Mussot, et al.
Pageof 33